(Received for publication June 22, 1998) The isolation and structure determination of 6 analogues of the fungal protein synthesis inhibitor GR135402, from Graphium putredinis, is described. The relative potencies of the compounds as protein synthesis inhibitors and as in vitro antifungal agents provide interesting insights into the structure-activity relationships in this series.
The novel acylated diterpene glycoside GR135402 (1) was discovered during a screening programme for inhibitors of fungal protein synthesis1). GR135402 is a 3'-(2-methyl-2, 4-hexadienoyl) derivative of the antifungal antibiotic sordarin discovered by workers at Sandoz in the 1960s2). Compounds with the same sordaricin skeleton have been reported from Zofiella marina (zofimarin, 5)3), Penicillium sp. F31405 (BE-31405)4), Xylaria sp. A19-915) and an unidentified fungal strain SCF1082A (SCH57404)6). GR135402 is highly selective for inhibition of fungal as opposed to mammalian protein synthesis1). This paper describes the isolation, characterisation and antifungal activity of minor components, related to 1, isolated from Graphium putredinis F13302.
Materials and Methods

Fermentation
Graphium putredinis F13302 was maintained on malt extract agar plates. Agar plugs (6mm dia.) were taken from the plates and used directly or stored in distilled water at ambient temperature. Seed cultures were inoculated with two agar plugs added to a 250ml
Erlenmeyer flask containing 50ml of seed medium of the following composition: peptone (Oxoid L34) 10g/litre, malt extract (Oxoid L39) 21g/litre, glycerol 40g/litre, Junlon PW110 (Honeywell and Stein Ltd., Wallington, Surrey, UK) 1g/liter, in distilled water. The pH of the medium was adjusted to 6.5 by the addition of NaOH before autoclaving. The flasks of inoculated seed medium were incubated on an orbital shaker rotating at 250 rpm 45 Litre Fermentation Further flasks (400ml seed medium per 2 litre flask) were inoculated using 0.5ml of seed culture and incubated as above. The contents of two of these seed flasks were pooled and used to inoculate a fermenter containing 45 litres of production medium of the following composition: arkasoy soy flour 15g, glycerol trioleate (Estol 1434) 10g, KH2PO4 1g, coarse heat treated wheat bran (Jas. Bowman & Sons Ltd., Hitchin, UK) 60g in 1 litre of tap water. The contents of the fermenter were aerated at 22.5 lpm and agitated at 500rpm. The culture was harvested after 5 days. (9:1). The eluate was evaporated to an aqueous residue and lyophilised to yield 2, 19mg.
Isolation of 3
processed and subjected to a second HPLC separation as for 2 above (4 injections). The fraction eluting at evaporated to an aqueous residue which was lyophilised to yield 3, 58mg.
Isolation of 4
and evaporated to an aqueous residue which was lyophilised to yield 4, 3.5mg.
Isolation of 7
was washed with water and eluted with CH3CN. The eluate was evaporated to a concentrate which was subjected to a second HPLC separation on the same column; mobile phase CH3CN-0.05M NH4H2PO4
(1:1); flow rate 120ml/minute; detection wavelength 266nm. A total of 9 injections were performed and fractions corresponding to 7 were bulked, diluted with an equal volume of water and pumped onto a column minute. The column was washed with water and eluted with CH3CN-H2O (9:1). The eluate was evaporated to an aqueous residue and lyophilised to yield 7, 160mg. 
Preparation of 9
To 1 (49mg) dissolved in MeOH (5ml) was added NaBH4 (approx. 3-fold excess). The solution was incubated with mixing at ambient temperature for 24 hours. The reaction mixture was diluted with 7 volumes of CH3CN-0.05M NH4H2PO4 (7:3) and 2 volumes of filtering, 9 was purified by preparative HPLC as described for 8 above except that the mobile phase was CH3CN-NH4H2PO4 (7:3). Appropriate fractions were Structure Determination NMR spectra were recorded on a Bruker AM500 using standard pulse sequences. Mass spectra were recorded on a Finnigan MAT TSQ700 mass spectrometer using a thermospray interface.
Protein Synthesis Inhibition
Inhibition of protein synthesis in cell-free preparations of Candida albicans was determined by assaying poly-uridine directed incorpration of L-[U-14C] phenylalanine into trichloroacetic acid precipitatable material as described previously1).
In Vitro Antifungal Activity
In vitro antifungal activity was determined by the agar dilution method with Iso-Sensitest agar (pH 7.4; Oxoid mined after 18 hours except for Aspergillus fumigatus and Cryptococcus neoformans (48 hours).
Results
Isolation of Antifungal Metabolites
Bioassay of fractions from analytical HPLC of extracts from the fermentation of Graphium putredinis F13302 revealed several components which were active in the assay for inhibition of protein synthesis in C. albicans. The stereochemistry indicated is relative within the sordaricin moiety and within the sugar moiety (see text).
The GR135402-related metabolites were extracted from the mycelium of Graphium putredinis with methanol and absorbed onto Partisil P40. After elution, components were purified by preparative HPLC.
Where appropriate, the fractionation was guided by using the Candida protein synthesis inhibition assay to locate the compounds of interest.
Structure Elucidation
The structures of the novel metabolites (Table 1) were determined by comparison of their NMR (Table 2) and MS data (Table 3) with that for the known compounds 11) and zofimarin3). No attempt was made to determine THE JOURNAL OF ANTIBIOTICS NOV. 1998 Table 2 . Proton NMR data in CDCl3a. the absolute stereochemistry but, especially considering the very similar biological properties, it is likely to be the same as for the known compound sordarin (8)7), ie as drawn. Compounds 2, 3, and 4 were clearly isomers of 1. The geometry of the 2"-3" double bond was established in each case from the chemical shift of the 3" proton.
Chemical shift additivity rules for alkenes8) indicate that geometry followed from the magnitude of the 4"-5" coupling constant. Chemical Derivatisation hydroxymethyl (9). Table 4 shows the activities of The compounds show interesting differences in biological activity. All the natural compounds tested are potent inhibitors of protein synthesis in Candida albicans and indeed the known compound sordarin (8), which lacks the 3'-O-acyl side chain, is equipotent with 1. The aldehyde group appears to be essential for protein synthesis inhibition as the borohydride reduction product, 9, was inactive.
In contrast, as regards whole cell antifungal activity in vitro, the nature of the 3'-O-acyl side chain had a profound effect on the potency of the compounds. Compound 3 was significantly less potent than 1 against all the fungi examined except for Candida pseudotropicalis. This suggests that the configuration of the double-bond at the 2", 3" position, but less so that at the 4", 5" position (see data for compound 2), is important for the in vitro antifungal activity. Zofimarin (5) lacking the 2"-methyl group, and the simple 3'-O-acetyl analogue, 6, were also substantially less potent than 1, as was the 6'-hydroxy compound, 7. The important role of the 3'-O-acyl group in conferring potent antifungal activity is further demonstrated by the modest potency of sordarin (8). The fact that compound 9 has some activity against Candida albicans, whilst not inhibiting protein synthesis, suggests that this might not be the sole mode-of-action of these compounds.
The importance of the 3'-O-acyl side-chain for whole cell antifungal activity together with its lack of influence on the protein synthesis inhibition may suggest that this moiety is important for uptake of the compounds into the fungi.
